Ethos Financial Group LLC Takes Position in Sabra Healthcare REIT, Inc. $SBRA

Key Points

• Ethos Financial Group LLC purchased a total of 65,823 shares of Sabra Healthcare REIT, Inc., valued at about $1,150,000, as reported in a recent Form 13F filing with the SEC.
• Sabra Healthcare REIT has announced a quarterly dividend of $0.30, representing an annual yield of 6.5%, with the ex-dividend date set for August 15th.
• The company exceeded earnings expectations with $0.38 earnings per share for the last quarter, surpassing analyst estimates by $0.02, and reported a 7.4% increase in revenue year-over-year.

Ethos Financial Group LLC bought a new position in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report) during the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor bought 65,823 shares of the real estate investment trust's stock, valued at approximately $1,150,000.

Other hedge funds have also recently bought and sold shares of the company. Allspring Global Investments Holdings LLC acquired a new position in Sabra Healthcare REIT during the 1st quarter worth about $298,000. New York State Teachers Retirement System lifted its stake in Sabra Healthcare REIT by 12.1% during the 1st quarter. New York State Teachers Retirement System now owns 321,647 shares of the real estate investment trust's stock worth $5,619,000 after acquiring an additional 34,591 shares in the last quarter. M&T Bank Corp lifted its stake in Sabra Healthcare REIT by 2.1% during the 1st quarter. M&T Bank Corp now owns 51,827 shares of the real estate investment trust's stock worth $905,000 after acquiring an additional 1,059 shares in the last quarter. Cambridge Investment Research Advisors Inc. lifted its stake in Sabra Healthcare REIT by 4.7% during the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 18,921 shares of the real estate investment trust's stock worth $331,000 after acquiring an additional 853 shares in the last quarter. Finally, Oppenheimer & Co. Inc. acquired a new position in Sabra Healthcare REIT during the 1st quarter worth about $578,000. Institutional investors and hedge funds own 99.40% of the company's stock.

Wall Street Analysts Forecast Growth

SBRA has been the topic of several research reports. JMP Securities increased their target price on Sabra Healthcare REIT from $20.00 to $22.00 and gave the stock a "market outperform" rating in a research note on Wednesday, August 6th. Scotiabank upped their price target on Sabra Healthcare REIT from $19.00 to $20.00 and gave the stock a "sector perform" rating in a report on Monday, June 23rd. One investment analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat, Sabra Healthcare REIT currently has an average rating of "Moderate Buy" and a consensus price target of $20.00.

Sabra Healthcare REIT Stock Up 2.9%

NASDAQ SBRA traded up $0.55 during trading hours on Wednesday, hitting $19.46. 2,858,793 shares of the company were exchanged, compared to its average volume of 2,460,579. The company has a 50 day moving average of $18.37 and a two-hundred day moving average of $17.64. The company has a quick ratio of 4.80, a current ratio of 4.80 and a debt-to-equity ratio of 0.91. Sabra Healthcare REIT, Inc. has a 52-week low of $15.60 and a 52-week high of $20.03. The firm has a market cap of $4.67 billion, a price-to-earnings ratio of 25.61, a PEG ratio of 1.54 and a beta of 0.86.

Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last issued its quarterly earnings results on Monday, August 4th. The real estate investment trust reported $0.38 earnings per share for the quarter, topping the consensus estimate of $0.36 by $0.02. Sabra Healthcare REIT had a return on equity of 6.69% and a net margin of 24.87%.The company had revenue of $189.15 million for the quarter, compared to the consensus estimate of $185.64 million. During the same quarter in the prior year, the business earned $0.36 EPS. Sabra Healthcare REIT's revenue was up 7.4% on a year-over-year basis. Sabra Healthcare REIT has set its FY 2025 guidance at 1.450-1.470 EPS. Equities research analysts anticipate that Sabra Healthcare REIT, Inc. will post 1.45 earnings per share for the current year.

Sabra Healthcare REIT Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, August 29th. Stockholders of record on Friday, August 15th will be issued a $0.30 dividend. The ex-dividend date is Friday, August 15th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 6.2%. Sabra Healthcare REIT's dividend payout ratio is presently 157.89%.

Sabra Healthcare REIT Company Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.